This wholesale & distribution business has Sellers open to remaining on board for 4 years and are willing to do a 30% carry or equity roll combo for a sign of a vested interest in the business’s success. With boosting sales of $29MM in 2021 the business is servicing clients in the B2B space. They have two primary client types of Small Wholesalers & direct Shop Owners. The business does not sell any traditional cannabis products but rather regulated hemp which allows them to totally legally sell across state lines. The business is operating out of a 12,000 sq. ft. distribution facility in Orange County and has a strong team of about 40 individuals who are experts in this industry. This includes a CFO, General Manager, VP of Sales, Retail Lead, 2 Manufacturing Leads, Warehouse Lead, 4 Warehouse Associates, 5 In House Sales Reps, 24 Packagers, and 19 Outside Sales Reps. They do not have any drivers, as this is all outsourced. They have unparalleled growth from 11 million to nearly 30 million over the last 24 months! This company focuses mainly on Distribution and Logistics to other much smaller wholesalers which makes up 59% of their revenue, while 38% is sold Business to Business directly to shop owners; less than 3% is sold direct to the consumer and this is intentional for research and development purposes.

Their services include wholesale, coordinating manufacturing, packaging & fulfillment, and arranging logistics, though that is outsourced to 3rd party freight companies. The current owners recently reinvested significant amounts of time and money into expanding operations, including moving toa distribution center twice the size to handle the growth, and they brought on Delta8, along with other unique products to continue being the industry leader. A buyer will be able to enjoy the spoils of this recent focus, but they will also have multiple opportunities to continue this growth trajectory. Note from the seller: “In response to any concerns regarding Vapes. Inhale-able products have gone from roughly 80% of sales last year to closer to 30% as we pivoted towards the edible products in 2022. This limits exposure to possible Inhale-able product legislation.” Currently there are 35 States who have recognized these Low-Dose consumables as a legal product and there are projected to be another 6-9 states that will follow suit in the next 6-9 months. Priced at $42,000,000, the seller is offering a combination of Promissory Note and Equity Roll for a total of 30% if desired by the buyer. This is a sign of good faith in the business continuing successfully. The 4.1 multiple on a business boasting a 2-year average $8,559,125 in cash flow, a 36% profit margin is a very fair ask, as they are looking for a strategic buyer for growth.

This fulfilment, wholesale, and distribution business has 4 subsidiaries, each with a unique product and target consumer. The products range from legalized low dose CBD to natural consumables. This market provides an alternative to western medicine and has helped users manage their pain without the fear of an addiction. The use of these products/alternative is on the rise and has helped people with Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Crohn’s Disease, Epilepsy and Seizures, Glaucoma, Multiple Sclerosis and Muscle Spasms, Severe and Chronic Pain, Severe Nausea or Vomiting caused by Cancer Treatment. There are several health benefits, as it is better for you than alcohol, helps to calm anxiety, and assists with PTSD. Individual states are continually expanding the legality of hemp and nicotine-based products, which allows for organic growth. The owner also sits on a major lobbying board that campaigns Congress constantly. As the health benefits of hemp and cannabis products continue to be shared, the client base for this business continues to grow. The goal for selling at this time is to expand with a Strategic Buyer or Equity Group who can bring strong business acumen and who may want to grow into manufacturing, bringing it in house to enhance profit margins.